BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8923077)

  • 1. An unusual cause for collapse in a patient with arthritis.
    Heath KJ; Sampson MJ; Ridley SA
    Intensive Care Med; 1996 Oct; 22(10):1096-7. PubMed ID: 8923077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is it Crohn's disease? A severe systemic granulomatous reaction to sulfasalazine in patient with rheumatoid arthritis.
    Quallich LG; Greenson J; Haftel HM; Fontana RJ
    BMC Gastroenterol; 2001; 1():8. PubMed ID: 11570976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulphasalazine-induced systemic lupus erythematosus in a patient with rheumatoid arthritis.
    Khattak FH; Morris IM; Mattingly PC
    Br J Rheumatol; 1996 Jan; 35(1):104. PubMed ID: 8624617
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphoma-like presentation in suspected rheumatoid arthritis due to sulphasalazine hypersensitivity syndrome.
    Shenoy P; Misra R; Jain M; Agarwal V
    N Z Med J; 2008 Jun; 121(1276):102-5. PubMed ID: 18574514
    [No Abstract]   [Full Text] [Related]  

  • 5. Seizures and hepatotoxicity following sulphasalazine administration.
    Sentürk T; Aydintuğ AO; Düzgün N; Tokgöz G
    Rheumatol Int; 1997; 17(2):75-7. PubMed ID: 9266624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin for sulphasalazine-induced aplastic anaemia in a patient with early rheumatoid arthritis.
    Nurmohamed MT; Soesan M; van Oers MH; Dijkmans BA; van Soesbergen RM
    Rheumatology (Oxford); 2000 Dec; 39(12):1431-3. PubMed ID: 11136894
    [No Abstract]   [Full Text] [Related]  

  • 7. DRESS syndrome induced by sulphasalazine in rheumatoid arthritis.
    Bejia I; Ben Hammouda S; Riahi K; Zinelabidine F; Mediouni B; Touzi M; Bergaoui N
    Joint Bone Spine; 2006 Dec; 73(6):764-5. PubMed ID: 16626997
    [No Abstract]   [Full Text] [Related]  

  • 8. [Severe drug hypersensitivity syndrome due to sulphasalazine in patient with rheumatoid arthritis].
    Gutierrez M; Filippucci E; Bugatti L; Bertolazzi C; Grassi W
    Reumatismo; 2009; 61(1):65-8. PubMed ID: 19370190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease.
    Borg AA
    Br J Rheumatol; 1995 Nov; 34(11):1097-8. PubMed ID: 8542218
    [No Abstract]   [Full Text] [Related]  

  • 10. Sulfasalazine induced lichen planus in a patient of rheumatoid arthritis.
    Ghosh S; Jain VK; Chaudhuri S; Mathur SK
    Indian J Dermatol Venereol Leprol; 2013; 79(4):541-4. PubMed ID: 23760333
    [No Abstract]   [Full Text] [Related]  

  • 11. Sulphasalazine lung toxicity: report of two cases.
    Karmakar GC; Wong CA; Horwood F; Anderson G
    N Z Med J; 2010 Aug; 123(1320):86-7. PubMed ID: 20720607
    [No Abstract]   [Full Text] [Related]  

  • 12. Bronchiolitis obliterans organizing pneumonia associated with sulfasalazine in a patient with rheumatoid arthritis.
    Ulubaş B; Sahin G; Ozer C; Aydin O; Ozgür E; Apaydin D
    Clin Rheumatol; 2004 Jun; 23(3):249-51. PubMed ID: 15168156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.
    Boers M; Verhoeven AC; Markusse HM; van de Laar MA; Westhovens R; van Denderen JC; van Zeben D; Dijkmans BA; Peeters AJ; Jacobs P; van den Brink HR; Schouten HJ; van der Heijde DM; Boonen A; van der Linden S
    Lancet; 1997 Aug; 350(9074):309-18. PubMed ID: 9251634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of the association between NAT2 gene haplotypes and severe adverse events with sulfasalazine therapy in patients with rheumatoid arthritis.
    Soejima M; Kawaguchi Y; Hara M; Kamatani N
    J Rheumatol; 2008 Apr; 35(4):724. PubMed ID: 18398952
    [No Abstract]   [Full Text] [Related]  

  • 15. The 3-week sulphasalazine syndrome strikes again.
    Lau G; Kwan C; Chong SM
    Forensic Sci Int; 2001 Nov; 122(2-3):79-84. PubMed ID: 11672959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritis.
    McInnes IB; Porter D; Murphy EA; Thomson EA; Madhok R; Hunter JA; Pullar T; Capell HA
    Ann Rheum Dis; 1996 May; 55(5):328-30. PubMed ID: 8660109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Life-threatening liver failure and severe dyscrasias in blood and lymph nodes caused by sulphasalazine].
    Kampmann P; Højlyng N; Pedersen M
    Ugeskr Laeger; 2006 Sep; 168(39):3331-3. PubMed ID: 17032600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Toxic epidermal necrolysis during therapy with sulphasalazine in a patient with arthritis. Case report].
    Rachwał-Siek K; Ponikowska M; Wiland P
    Wiad Lek; 2011; 64(4):283-7. PubMed ID: 22533153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfasalazine-induced hypersensitivity: a case report of DRESS syndrome.
    Yeşilova Z; Kantarcioğlu M; Erçin CN; Safalioğlu M; Kilciler G; Koç E; Atli M; Uygun A
    Turk J Gastroenterol; 2009 Dec; 20(4):298-9. PubMed ID: 20084578
    [No Abstract]   [Full Text] [Related]  

  • 20. Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodium.
    Choy EH; Scott DL; Kingsley GH; Williams P; Wojtulewski J; Papasavvas G; Henderson E; Macfarlane D; Erhardt C; Young A; Plant MJ; Panayi GS
    Clin Exp Rheumatol; 2002; 20(3):351-8. PubMed ID: 12102471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.